EpiBone, Inc. is a privately-held regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that have the potential to integrate seamlessly into patients' bodies. EpiBone is currently developing a pipeline of bone, cartilage, and other skeletal tissue products.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/09/24 | undisclosed | Convertible Debt |
EMV Capital Kendall Capital Partners  LifeSpan Vision Ventures | undisclosed |
